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ABSTRACT
The European Food Safety Authority (4) reported that Campylobacter
infections still topped the list of zoonotic diseases in the European Union 
whereas the number of Salmonella infections in humans fell for the fourth year 
and the number of listeriosis remained in the same level. 
The antimicrobial resistance of Campylobacter spp. has been increasing 
worldwide. In general, the campylobacterisis is resolved without antimicrobial 
intervention; however, treatment is crucial to manage severe or invasive 
illness. In the present study, several strains of Campylobacter jejuni (n=159) 
collected from poultry food products (61%) and from clinical cases of 
campylobacterisis occurred in Portugal (39%) were evaluated concerning their 
antibiotic susceptibility.
MATERIALS AND METHODS
The minimal inhibitory concentration (MIC) of each antibiotic was 
determined according to the method of agar dilution described by
CLSI (1).
Enterococcus faecalis ATCC 29212 and Staphylococcus aureus 
ATCC 29213 were used as controls. The tested antibiotics were: 




0.6%, 5.6%, 30%, 74%, 60% and 80% of C. jejuni isolates were resistant to chloramphenicol, 
gentamicin, erythromycin, tetracycline, nalidixic acid and ciprofloxacin, respectively (2, 3). 
The resistance to antibiotics was showed to be dependent on the origin of the isolates (food or 
clinical). In fact, and for all the tested antibiotics, the MIC50 for the food isolates was higher 
than the MIC50 for the clinical isolates. The differences among the susceptibility through 
antibiotics might be related to the overuse of antibiotics in the veterinary medicine. On the 
other hand, the resistance of the bacteria can be transmitted to human and thus affect the 
human health. 
Figure 2  - Minimal inhibitory concentrations distributions of 
tetracycline for Campylobacter jejuniFigure 1 – Minimal inhibitory concentration distributions of chloramphenicol for Campylobacter jejuni.
Figure 3 – Minimal inhibitory concentrations distributions of 
erythromycin for Campylobacter jejuni
Figure 4 – Minimal inhibitory concentrations distributions of nalidixic 
acid for Campylobacter jejuni
Figure 5 – Minimal inhibitory concentrations distributions of 
gentamicin for Campylobacter jejuni 
Figure 6 – Minimal inhibitory concentrations distributions of 
ciprofloxacin for Campylobacter jejuni
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